{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:21:16Z","timestamp":1793690476834,"version":"4.5.1"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Although deoxycholic acid (DCA) has been proposed for use in other areas, it is used primarily for treating moderate-to-severe fat in the submental area.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To evaluate the safety and efficacy of DCA for fat reduction in the hypogastric region.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>A prospective, longitudinal, nonrandomized, open-label, interventional pilot study was performed. Deoxycholic acid was transcutaneously injected in upper right, upper left, lower right, and lower left hypogastric zones. Fat thickness was assessed using calipers, ultrasound, and 3-dimensional scanning. The primary end point safety was evaluated by laboratory tests and the incidence of adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Fourteen patients (54 treatment sessions) were included. The mean total volume administered was 26.6 mL. The main local adverse events were edema (94.4%), bruising (90.7%), and erythema (79.6%), all being self-limited (the mean duration 9.6, 7, and 2 days, respectively). A DCA dose was significantly associated with erythema duration (<jats:italic toggle=\"yes\">p<\/jats:italic> = .0421) but not with edema duration (<jats:italic toggle=\"yes\">p<\/jats:italic> = .1611) or bruising incidence (<jats:italic toggle=\"yes\">p<\/jats:italic> = .1013). Measurement using calipers, ultrasound, and 3-dimensional scanning revealed significant fat thickness reduction. Patient-reported outcome measure scores revealed a significant improvement in patient satisfaction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Deoxycholic acid may be a safe and effective option for reducing fat thickness in the hypogastric region, although given the cost\/benefit ratio probably should be reserved for small deposits.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000002823","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T21:04:30Z","timestamp":1617311070000},"page":"e132-e137","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Safety and Efficacy of Deoxycholic Acid Injection for Hypogastric Fat Reduction: A Pilot Study"],"prefix":"10.1097","volume":"47","author":[{"given":"Laura","family":"Salvador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Benito-Ruiz","sequence":"additional","affiliation":[{"name":"Both authors are affiliated with the Antiaging Group Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250731","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/jdv.12994","article-title":"Non-invasive subcutaneous fat reduction: a review","volume":"29","author":"Kennedy","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R2-20250731","doi-asserted-by":"crossref","first-page":"e36727","DOI":"10.5812\/ijem.36727","article-title":"Review of the mechanisms and effects of noninvasive body contouring devices on cellulite and subcutaneous fat","volume":"14","author":"Alizadeh","year":"2016","journal-title":"Int J Endocrinol Metab"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/jdv.12377","article-title":"Efficacy, patient-reported outcomes and safety profile of ATX-101 (deoxycholic acid), an injectable drug for the reduction of unwanted submental fat: results from a phase III, randomized, placebo-controlled study","volume":"28","author":"Ascher","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jaad.2016.04.028","article-title":"ATX-101 for reduction of submental fat: a phase III randomized controlled trial","volume":"75","author":"Humphrey","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/DSS.0000000000000578","article-title":"REFINE-1, a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial with ATX-101, an injectable drug for submental fat reduction","volume":"42","author":"Jones","year":"2016","journal-title":"Dermatol Surg"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/bjd.12695","article-title":"Reduction of unwanted submental fat with ATX-101 (deoxycholic acid), an adipocytolytic injectable treatment: results from a phase III, randomized, placebo-controlled study","volume":"170","author":"Rzany","year":"2014","journal-title":"Br J Dermatol"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00266-014-0364-9","article-title":"Results from a pooled analysis of two European, randomized, placebo-controlled, phase 3 studies of ATX-101 for the pharmacologic reduction of excess submental fat","volume":"38","author":"McDiarmid","year":"2014","journal-title":"Aesthet Plast Surg"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/asj\/sjy008","article-title":"Efficacy and safety of ATX-101 by treatment session: pooled analysis of data from the phase 3 REFINE trials","volume":"38","author":"Dayan","year":"2018","journal-title":"Aesthet Surg J"},{"key":"R10-20250731","first-page":"675","article-title":"Non-submental applications of injectable deoxycholic acid: a systematic review","volume":"18","author":"Sung","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/1090820X13478630","article-title":"Metabolic and structural effects of phosphatidylcholine and deoxycholate injections on subcutaneous fat: a randomized, controlled trial","volume":"33","author":"Reeds","year":"2013","journal-title":"Aesth Surg J"},{"key":"R13-20250731","first-page":"870","article-title":"ATX-101 (deoxycholic acid injection) for reduction of submental fat: results from a 12-month open-label study","volume":"18","author":"Beer","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"R14-20250731","first-page":"639","article-title":"ATX-101 (deoxycholic acid injection) leads to clinically meaningful improvement in submental fat: final data from CONTOUR","volume":"46","author":"Behr","year":"2020"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/DSS.0000000000001811","article-title":"Real-world experience with 100 consecutive patients undergoing neck contouring with ATX-101 (deoxycholic acid): an updated report with A 2-year analysis","volume":"45","author":"Shridharani","year":"2019","journal-title":"Dermatol Surg"},{"issue":"Suppl 1","key":"R16-20250731","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1097\/DSS.0000000000000875","article-title":"Proper technique for administration of ATX-101 (deoxycholic acid injection): insights from an injection practicum and roundtable discussion","volume":"42","author":"Jones","year":"2016","journal-title":"Dermatol Surg"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"e1085","DOI":"10.1097\/GOX.0000000000001085","article-title":"Intralipotherapy, the state of the art","volume":"4","author":"Amore","year":"2016","journal-title":"Plast Reconstr Surg Glob Open"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002823","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:13:06Z","timestamp":1753999986000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000002823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000002823","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"value":"1076-0512","type":"print"},{"value":"1524-4725","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}